Detalles de la búsqueda
1.
Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study.
Biol Pharm Bull;
47(2): 411-416, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346748
2.
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy.
Breast Cancer;
31(2): 283-294, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175422
3.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Breast Cancer;
30(6): 872-884, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804479
4.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Breast Cancer Res Treat;
202(3): 473-483, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37688665
5.
Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
Breast Cancer;
30(5): 831, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395979
6.
Metastasis-directed therapy for oligometastases in breast cancer.
Jpn J Clin Oncol;
53(10): 893-898, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37424379
7.
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial.
Front Oncol;
13: 1216813, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37483483
8.
Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
Breast Cancer;
30(5): 820-830, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310584
9.
The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.
Cancer Rep (Hoboken);
6(2): e1695, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806718
10.
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
Acta Med Okayama;
76(6): 661-671, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36549768
11.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci;
113(9): 3169-3179, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35754298
12.
Assessment of a cancer genomic profile test for patients with metastatic breast cancer.
Sci Rep;
12(1): 4813, 2022 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315838
13.
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
Cancer Sci;
113(5): 1808-1820, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35201661
14.
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
BMC Cancer;
22(1): 36, 2022 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34983437
15.
Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
Breast Cancer;
29(1): 186-188, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34562260
16.
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
Breast Cancer;
29(1): 131-143, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34491513
17.
Pembrolizumab plus chemotherapy in triple-negative breast cancer.
Lancet;
398(10294): 24, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217392
18.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Acta Med Okayama;
75(3): 357-362, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176940
19.
A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
Clin Breast Cancer;
21(5): 450-457, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33685834
20.
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Breast Cancer;
28(4): 896-903, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599914